BLUE JET HEALTHCARE LTD

Blue Jet Healthcare Limited held its Q1 FY27 Earnings Conference Call on August 3, 2026, where management reported a revenue of INR 293 crores and an EBITDA of INR 98 crores, indicating a healthy sequential improvement. The Managing Director, Shiven Arora, noted that the quarter reflected improving business momentum, particularly in the PI vertical, and highlighted the commencement of execution activities at the Vizag project. The Chief Operating Officer, V.K. Singh, discussed the establishment of a globally scaled manufacturing facility for contrast media intermediates and the ongoing development of the Hyderabad R&D center. CFO Ganesh Karuppannan provided insights into financial performance, noting a 25% increase in turnover compared to the previous quarter, despite challenges in the contrast media segment due to transit delays. The management emphasized their commitment to long-term growth through strategic investments and innovation in manufacturing capabilities.

Management highlighted improvements in operational performance and strategic initiatives.